Patent · US Active

Amorphous form of a complement component C5a receptor

US11603356B2 · kind B2 · utility

0Cited by

10References

43Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Kwok YAU · Sunnyvale, US
Kenken Luong · San Jose, US
Rajinder Singh · Belmont, US
Yibin Zeng · Foster City, US
Penglie Zhang · Foster City, US
Manmohan Reddy Leleti · Sunnyvale, US
Rebecca M. Lui · Mountain View, US

Key dates

Filing date	Nov 6, 2020
Grant date	Mar 14, 2023
Priority date	—
Expiry date	May 29, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein is an amorphous form of a complement component 5a receptor having the formula of Compound 1Also provided herein are pharmaceutical compositions and methods of treatment using the amorphous form of Compound 1, described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.